Ledger.Open graph →
SEC Form D · Amendment · filed June 26, 2024

Phi Therapeutics, Inc

Offering
$7.7M
Sold
$7.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PETALUMA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Yug Varma · PETALUMA, CAExec · DirectorNeil Giugno · PETALUMA, CAExec · DirectorJun Li · PETALUMA, CADirectorYew Poh Leong · Singapore, U0Exec · DirectorMike Zelkind · Hamilton, OHDirectorHsien Loong Wong · Singapore, U0Exec · DirectorKevin Law · New York, NYDirectorJames Cleary · Grand Cayman, Cayman IslandsDirectorAnne Wynne · New York, NYExec · DirectorJohn W. Honeybourne · Houston, TXExec · DirectorKevin Law · PETALUMA, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗